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Acute ethanol activates the hypothalamic–pituitary–adrenal (HPA) axis, while long-term 
exposure results in a blunted neuroendocrine state, particularly with regards to the 
primary endpoint, cortisol, the primary glucocorticoid produced in the adrenal cortex. 
However, it is unknown if this dampened neuroendocrine status also influences other 
adrenocortical steroids. Plasma concentration of the mineralocorticoid and neuroactive 
steroid precursor deoxycorticosterone (DOC) is altered by pharmacological challenges 
of the HPA axis in cynomolgus monkeys. The present study investigated HPA axis reg-
ulation of circulating DOC concentration over the course of ethanol (4% w/v) induction 
and self-administration in non-human primates (Macaca fasciculata, n = 10). Plasma 
DOC, measured by radioimmunoassay, was compared at baseline (ethanol naïve), during 
schedule-induced polydipsia, and following 6-months of 22  h/day access to ethanol 
and water. The schedule induction of ethanol drinking did not alter basal DOC levels 
but selectively dampened the DOC response to pharmacological challenges aimed 
at the anterior pituitary (ovine corticotrophin-releasing hormone) and adrenal gland 
(post- dexamethasone adrenocorticotropin hormone), while pharmacological inhibition 
of central opioid receptors with naloxone greatly enhanced the DOC response during 
induction. Following 6  months of ethanol self-administration, basal DOC levels were 
increased more than twofold, while responses to each of the challenges normalized 
somewhat but remained significantly different than baseline. These data show that 
HPA axis modulation of the neuroactive steroid precursor DOC is markedly altered 
by the schedule induction of ethanol drinking and long-term voluntary ethanol self- 
administration. The consequences of chronic ethanol consumption on HPA axis regula-
tion of DOC point toward allostatic modification of hypothalamic and adrenal function.
Keywords: deoxycorticosterone, hypothalamic–pituitary–adrenal axis, cynomolgus monkey, ethanol, schedule 
induction of ethanol, ethanol self-administration
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inTrODUcTiOn
Endogenous stress systems are sensitive to pharmacological 
doses of ethanol as well as the conditions under which ethanol 
is made available to the organism. The hormonal response to 
stress in alcoholics involves all three components of the hypo-
thalamic–pituitary–adrenal (HPA) axis and depends on whether 
they are intoxicated, actively drinking but not intoxicated, in 
acute withdrawal, or in abstinence. Intoxication (1) and with-
drawal (2–4) are associated with increased cortisol secretion 
in alcohol-dependent patients, which may depend on whether 
withdrawal is abrupt (5). In non-intoxicated, non-abstinent 
alcoholics, adrenocorticotropin hormone (ACTH) response to 
corticotrophin-releasing hormone (CRH) was blunted relative 
to controls and the time to peak ACTH was delayed in half the 
subjects (6). Cortisol response to ACTH was blunted, indicative 
of adrenal insufficiency (6), similar to blunted salivary cortisol 
during a stress imagery procedure (7). Altered pituitary response 
to CRH and adrenocortical response to ACTH in alcoholics 
may recover with abstinence (4, 8). Other studies have found 
abstinent alcoholics have greater basal ACTH (9), lower levels 
of the cortisol precursor 11-deoxycortisol and a reduced cortisol 
response to exogenous ACTH administered after dexamethasone 
(10). Furthermore, ACTH [early abstinence (11, 12)] and cortisol 
after pituitary stimulation by CRH are lower in abstinent alcohol-
ics [1-month abstinence (9)]. Blocking inhibitory opioid input to 
CRH neurons in the hypothalamus with the μ-opioid receptor 
antagonist naloxone elevated HPA response (13), and this effect 
is decreased in early (11) but not later (9) abstinence as measured 
by ACTH. Finally, abstinent alcoholic men (10), but not women 
(14), had lower dexamethasone (8 mg, i.v.) suppression of ACTH 
and cortisol compared to controls. Overall these data suggest 
adaptations during chronic ethanol intoxication in state depend-
ent and likely occur at each level of the HPA axis.
The HPA axis response to ethanol has been suggested as 
a risk factor for developing alcoholism, and acute, low doses 
of ethanol suppress cortisol more among alcohol-drinking 
sons of alcoholics than controls (15). Human studies have the 
potential confounds of self-selection (non-randomized) drink-
ing status, use of other substances and comorbidities associated 
with early-onset  alcohol drinking and dependence such as life 
stress, anxiety, and depression. Studies in rodents are limited, as 
rodents do not have adrenal anatomy and physiology similar to 
human and non-human primates. Specifically, rodents do not 
have a 3-layer adrenal cortex, as the zona reticularis is absent 
(16). Biochemically, there are key differences in steroidogenesis 
between rodents and primates. For example, human cytochrome 
P450c17 enzyme rapidly converts 17α-hydroxypregnenolone 
to dehydroepiandrosterone (DHEA), the principal source of 
androgens in humans. In contrast, rodent P450c17 efficiently 
converts 17α-hydroxyprogesterone to androstenedione, the main 
source of androgens in rodents (17). Furthermore, adult rats 
have low activity of 5β-reductase (18), and 5β-reduced neuroac-
tive metabolites are low or undetectable basally (19), indicating 
species differences in the balance of neuroactive metabolites. In 
addition, non-human primates share with humans the propensity 
to self-administer large quantities of ethanol over months and 
years, with similar absorption and metabolism (20, 21). These 
differences suggest monkeys are excellent models for studying the 
interaction between steroid and neuroactive steroid metabolites 
and ethanol self-administration.
Deoxycorticosterone (DOC) is a mineralocorticoid syn-
thesized in the zona fasciculata and zona glomerulosa of the 
adrenal gland. It is a metabolite of progesterone, and a precursor 
of the glucocorticoid corticosterone and the mineralocorticoid 
aldosterone. Neuroactive metabolites of DOC, including 
(3α,5α)-3,21-dihydroxypregnan-20-one (THDOC), positively 
modulate γ-aminobutyric acid type A (GABAA) receptors 
(22), and produce subjective effects that resemble ethanol 
as shown using drug discrimination (23). As GABAA recep-
tors are a key receptor mechanism underlying the subjective 
interoceptive response to ethanol in primates (24), circulating 
neuroactive precursors, such as DOC, could alter ethanol self-
administration. In addition to modulation of ionotropic recep-
tor systems such as GABAA, neuroactive steroid precursors may 
interact with ethanol self-administration through other receptor 
systems. For example, mineralocorticoid receptors in the baso-
lateral amygdala have been implicated in decreased anxiety-like 
behavior and decreased corticosterone in rodents (25). Thus, 
circulating and brain concentrations of mineralocorticoids and 
glucocorticoids may alter temperament, such as anxiousness, or 
other characteristics contributing to the risk of heavy ethanol 
consumption.
In cynomolgus monkeys, circulating levels of DOC are altered 
by pharmacological challenges to the HPA axis that isolate 
anatomical contributions to the stress response. Specifically, 
DOC is increased by injections of naloxone (hypothalamic) and 
CRH (pituitary), suppressed by dexamethasone (hypothalamic, 
pituitary, adrenal), but unchanged by ACTH (adrenal) or ethanol 
[1.0 g/kg or 1.5 g/kg, i.g., blood ethanol concentration (BEC) up 
to 147 mg/dl (26);]. In a study using low stress, resting conditions 
(i.e., remaining in the home cage) and in the absence of challenges 
to the HPA axis (i.e., a basal state), plasma DOC in ethanol-naïve 
male rhesus monkeys was negatively correlated with average 
longitudinal BEC measures across more than 12 months of daily 
access to ethanol and water (27). Among five hormones measured 
at baseline and after more than 12 months of daily ethanol access, 
DOC and aldosterone distinguished heavy from non-heavy 
drinkers; aldosterone positively correlated with both water and 
ethanol intake but not with level of intoxication as represented by 
average BEC. These data suggest that resting levels of DOC may 
have a unique predictive (negative) relationship with drinking to 
intoxication. In our earlier studies, DOC after saline, CRH, nalox-
one, or ACTH challenges in ethanol-naïve cynomolgus monkeys 
was not predictive of future ethanol self-administration, though 
the capacity of dexamethasone to suppress DOC in these subjects 
was negatively correlated with heavy drinking (26).
To date, the effect of chronic ethanol self-administration on 
HPA axis regulation of DOC is unknown. The present study 
reports basal DOC and its HPA axis regulation by each level of the 
HPA axis throughout the course of ethanol induction and self-
administration. We hypothesized that ethanol self-administration 
would decrease adrenal sensitivity leading to a disruption in HPA 
axis stimulation of circulating DOC.
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MaTerials anD MeThODs
animals
Adult male cynomolgus monkeys (n =  10 Macaca fascicularis, 
70–85 months old when schedule induction started) were indi-
vidually housed in 76 cm × 60 cm × 70 cm stainless steel cages in 
an environment maintained at 21 ± 1°C, with 30–50% humidity 
and a 11:13-h light cycle (lights on, 7:00 a.m.). All monkeys were 
maintained in a positive caloric and fluid balance throughout the 
experiment, as previously reported (26). This study was approved 
by the Wake Forest University Animal Care and Use Committee 
and conducted in accordance with both the Wake Forest 
University Animal Care and Use Committee guidelines and the 
guidelines for the care and use of laboratory animal resources 
(Commission on Life Sciences, National Research Council, 1996; 
NIH Guide for the Care and Use of Laboratory Animals).
The monkeys were trained using positive reinforcement 
to comply with awake venipuncture to collect blood for the 
steroid assays, as described elsewhere (26). To administer the 
pharmacological challenges, the monkeys were trained to sit in 
a primate chair using positive reinforcement for insertion of a 
intravenous catheter and nasogastric gavage using an infant feed-
ing tube (5 French, 1.7 × 381 mm). During training, tap water 
was administered in volumes approximating volumes for ethanol 
administration during testing. All challenges of the HPA axis, 
except for the dexamethasone challenge, were conducted in the 
primate chairs.
Blood sampling
Femoral blood samples were obtained with a 22-g  ×  1-inch 
Vacutainer needle and a 3-ml Vacutainer hematology tube 
(Becton Dickinson, Franklin Lakes, NJ, USA). All blood samples 
were stored on ice (approximately 15  min) until centrifuged 
(3,000 rpm, 15 min at 4°C, Model Allegra 21R, Beckman Coulter, 
Fullerton, CA, USA). Plasma samples (100-µl aliquots) were 
frozen at −80°C and stored in 2-ml microtubes until processing.
ethanol self-administration
The procedure for schedule induction and maintenance of long-
term ethanol self-administration is described in detail elsewhere 
(20, 28, 29). Briefly, monkeys were trained to operate a drinking 
panel (Med-Associates, Inc., St. Albans, VT, USA) attached to one 
wall of each monkey’s home cage. All fluid was available through 
two spouts activated by pulling a centrally located dowel, one for 
water and another for ethanol, and food requirements by pressing 
a push panel. Initially, fluid was available through the right-side 
drinking spout, and one press on the push panel resulted in pres-
entation of a 1-g banana-flavored pellet (carbohydrate: 63%; fat: 
4%; protein: 22%; PJ Noyes, Lancaster, NH, USA). Training was 
complete (approximately 2–3  weeks) once the monkey reliably 
pulled the dowel to activate the panel, drank from the spouts, 
and received all available food pellets by responding on the push 
panel. Subsequently, monkeys were induced to consume water 
under fixed-time pellet delivery to establish schedule-induced 
polydipsia (SIP). Monkeys were induced to drink 150–250 ml of 
water (corresponding to the volume necessary to self-administer 
an ethanol dose of 1.5 g/kg, with a concentration of 4% w/v) each 
day for 30 days. Monkeys were then induced to drink 0.5 g/kg of 
ethanol (4% w/v) per day for 30 consecutive days, 1.0 g/kg/day for 
30 consecutive days, and finally 1.5 g/kg/day for 30 consecutive 
days. After schedule induction, all monkeys had 22 h/day open 
access to ethanol and water for approximately 6 months, and the 
daily allotment of food was available in three equal “meals” avail-
able at the start of the daily session and each separated by 2 h. 
Summaries of the ethanol self-administration data are available 
online (www.MATRR.com; cynomolgus cohort 1).
Pharmacological Profiling of the hPa axis
Each of six pharmacological challenges [naloxone, ovine CRH 
(oCRH), ACTH, dexamethasone, and ethanol (two doses)] was 
conducted at baseline, after schedule induction and after 6 months 
of ethanol access between 8:00 a.m. and 2:00 p.m. (lights on at 
7:00 a.m.). Two challenges per week were conducted, requiring 
4  weeks to complete all challenges: Week 1, dexamethasone 
(130 µg/kg, intramuscular) on Monday/Tuesday, ACTH (0.5 mg/
kg intramuscular dexamethasone followed 4–6  h by 10  ng/kg 
intravenous Cortrosyn) on Thursday; Week 2, naloxone 375 µg/
kg on Friday; Week 3, saline (0.35 ml intramuscular) on Tuesday, 
ethanol (1.0 g/kg, intragastric) on Friday; Week 4, ethanol (1.5 g/
kg, intragastric) on Tuesday, CRH (1  µg/kg, intravenous) on 
Friday. The procedure for each challenge differed according to 
the challenge. For the dexamethasone suppression test, blood was 
obtained pre-dexamethasone (8:00 a.m.), dexamethasone was 
administered at 10:00 p.m. the same day, and the next morning 
(8:00 a.m.) another blood sample (post-dexamethasone) was 
obtained. For the ACTH challenge, the monkeys were admin-
istered dexamethasone after an overnight fast. Four to six hours 
later, a baseline blood sample was obtained and ACTH adminis-
tered. Blood was obtained 15 and 30 min after ACTH infusion. 
After naloxone was administered, blood was collected at 15, 30, 
60, 90, and 120 min. Blood samples were obtained 30 min before 
ethanol administration then 15, 60, 90, and 120  min after. For 
the ethanol challenges, BEC was measured from the 60, 90, and 
120 min samples. For the CRH challenge, a baseline blood sample 
was collected 30-min prior to administration of oCRH and 15, 30, 
and 60 min after administration.
These studies were designed to allow adequate time between 
endocrine challenges. After five half-lives, a drug is effectively 
cleared from circulation. In the case of dexamethasone, which has 
the longest half-life of the drugs used in these studies (approxi-
mately 190 min in humans), this would be cleared in less than 
16 h. Pharmacological challenges were separated by a minimum 
of 72  h. While the immediate effects of these pharmacological 
challenges would be gone, there is a possibility that they cause 
a longer lasting effect. To control for this, the challenges were 
performed in the same order at each experimental phase. In 
humans the half-life of the other drugs use are as follows: nalox-
one (64 ±  12  min), oCRH (43 ±  6  min), ACTH (intravenous, 
15 min), and dexamethasone (190 min).
Drugs
Naloxone hydrochloride dihydrate and oCRH were purchased 
from Sigma-Aldrich Co., St. Louis, MO, USA. ACTH (Cortrosyn; 
FigUre 1 | Basal deoxycorticosterone (DOc) (a) and adrenocorticotropin hormone (acTh) (B) measured from samples collected while animals were 
in their home cage in the absence of pharmacological challenge. Dexamethasone suppression (percent of baseline) of DOC (c) and ACTH (D). Animals are 
uniquely colored. ap < 0.05, *p < 0.01, **p < 0.001, ***p < 0.0001.
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0.25  mg/vial reconstituted with sterile saline; Amphastar 
Pharmaceuticals, Inc., Rancho Cucamonga, CA, USA) and dexa-
methasone (10 and 4 mg/ml for the ACTH and dexamethasone 
profiles, respectively; Baxter, Deerfield, IL, USA) were obtained 
in a commercial formulation from the Wake Forest University 
Baptist Medical Center pharmacy. All drugs were diluted in 
sterile saline to make the appropriate concentrations. Ethanol 
(95%, Warner-Graham, Cockeysville, MD, USA) was diluted in 
tap water to a concentration of 20% (w/v) for the 1.0 g/kg dose 
and 30% (w/v) for the 1.5  g/kg dose to keep volume constant 
across both doses.
DOc assay
All plasma samples were assayed for DOC using radioimmu-
noassay (RIA) as previously described (26). Briefly, plasma sam-
ples (200 µl) were extracted twice with 2 ml ethyl acetate/hexane 
(3:2); 1,000  cpm of [3H]DOC (SpA =  50  Ci/mmol; American 
Radiolabeled Chemicals, Inc., Saint Louis, MO, USA) were added 
to each sample for recovery estimation. The dried extracts were 
resuspended in 1.5 ml RIA buffer of which 0.5 ml were used for 
the assay (run in duplicate) and 0.3  ml were used for recovery 
determination. Each assay included a rat plasma sample as an 
internal control. The antiserum for DOC was purchased from 
MP Biomedicals (Solon, OH, USA) and diluted according to 
manufacturer’s instructions. This antiserum was highly specific 
for DOC as shown by the following cross-reactivity tests: DOC 
100%, 3α,5α-THDOC 4.7%, progesterone 2.5%, corticosterone 
1.7%. Less than 1% cross-reactivity was observed for (3α,5α)-3-
hydroxypregnan-20-one (3α,5α-THP), 3α-hydroxy-pregn-4-en-
20-one, pregnenolone, 20-hydroxy-pregnen-4,3-one, testosterone, 
androstenedione, 17α-hydroxyprogesterone, 11-deoxycortisol, 
5α-dihydrotestosterone, cortisol, cholesterol, 17β-estradiol, 
estrone, and estriol. Unknown samples were compared to con-
currently run standards using a one-site competition model and 
adjusted for extraction efficiency. DOC values are expressed as 
nanograms per milliliter of plasma. The sensitivity of the assay is 
10 pg/ml. Intra-assay and inter-assay coefficients of variation were 
4.86 and 4.51%, respectively. ACTH was assayed in duplicate at 
Yerkes Endocrine Core Laboratory (Atlanta, GA, USA) using a 
commercially available kit (DiaSorin kit #24130; Stillwater, MN, 
USA), with sensitivity of 6.8–436.0 pg/ml.
Data analysis
Area under the curve (AUC) was calculated using the trap-
ezoidal method. Basal, AUC, and peak concentrations were 
log-transformed, when necessary, prior to statistical analysis. 
The effects of pharmacological challenges on plasma DOC were 
analyzed using linear mixed-effect models with monkey as the 
subject variable and experimental phase (three levels: baseline, 
induction, and self-administration) as the independent variables. 
Significant results are reported based on post  hoc comparisons 
using Tukey-corrected t-tests. All analyses were conducted using 
R 2.15.3 (R Core Team, 2015), α < 0.05. All data are presented as 
mean ± SD unless stated otherwise.
resUlTs
Basal DOc
All animals were trained to participate in awake venipuncture 
and had been doing so each week in their home cage for over 
6 months prior to collection of the samples reported here. This 
protocol reliably produces low levels of circulating stress hormones 
(30, 31). Under this low stress condition, basal DOC increased 
over the course of the experiment [F(2,18) = 45.0, p < 0.0001, 
Figure 1A]. Compared to baseline (0.28 ± 0.06 ng/ml) and induc-
tion (0.37 ± 0.16 ng/ml), DOC had increased twofold following 
6-months of ethanol self-administration (0.74  ±  0.19  ng/ml; 
p < 0.0001). This was intriguing, as we have previously reported 
a positive correlation between plasma ACTH and DOC (26) 
and that ACTH is elevated during ethanol induction (32). Given 
this relationship, we assayed ACTH from the same samples. As 
we have previously reported, ACTH varied by experimental 
phase [F(2,18) = 19.1, p < 0.0001, Figure 1B] and was highest 
during induction (54.2  ±  17.4  pg/ml) compared to baseline 
(35.3 ± 11.7 pg/ml; p < 0.0004) and 6 months self-administration 
(29.5 ± 8.2 pg/ml; p < 0.0004). Under induction, ACTH, but not 
cortisol, is elevated for prolonged periods of time (32). These data 
suggest that while DOC concentration is influenced by HPA axis 
activation, it is not directly linked to circulating ACTH.
During open access, the average daily consumption ranged 
from 1.2 to 4.2 g/kg/day, with a group average (mean ± SEM) of 
2.7 ± 0.3 g/kg/day. Average daily consumption was not correlated 
with basal DOC [baseline: r(9) = −0.33, p =  0.36; induction: 
FigUre 2 | exogenous acTh (10 ng/kg, 4–6 h after 0.5 mg/kg dexamethasone) stimulation of circulating deoxycorticosterone (DOc). DOC response is 
summarized across the experimental phases by area under the curve (a). DOC concentrations for each timepoint sampled during baseline (B), induction (c), and 
self-administration (D) are shown. Symbols represent significant differences when compared to baseline (t = −15min). Animals are uniquely colored. ap < 0.05, 
**p < 0.001, ***p < 0.0001.
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r(9) = −0.07, p = 0.85; 6 months: r(9) = 0.17, p = 0.64] or ACTH 
[baseline: r(9) = 0.04, p = 0.91; induction: r(9) = −0.34, p = 0.34; 
6 months: r(9) = 0.06, p = 0.87].
Dexamethasone suppression Test
We have previously reported that DOC is modulated by the HPA 
axis in non-human primates (26). Additionally, an extensive liter-
ature describes the consequences of long-term alcohol consump-
tion on HPA axis function. We aimed to further understand the 
interaction between HPA axis activation and DOC within subject 
across a well-validated model of ethanol self-administration. One 
well-documented consequence of HPA axis over-activation is 
decreased sensitivity to glucocorticoid negative feedback (10, 14). 
Dexamethasone is a synthetic glucocorticoid with high affinity 
for the glucocorticoid receptor and is used to measure sensitivity 
to negative feedback. Ethanol induction differentially influenced 
sensitivity to dexamethasone suppression for both DOC and 
ACTH [DOC: F(2,18) = 4.20, p = 0.032; ACTH: F(2,17) = 6.67, 
p  =  0.007; Figures  1C,D]. DOC showed greater suppression 
during induction compared to baseline (p = 0.01), while ACTH 
was less sensitive to dexamethasone suppression during induc-
tion when compared to both baseline and self-administration 
(p = 0.001 and p = 0.038, respectively).
Post-Dexamethasone acTh challenge
Each challenge had unique sample collection times, which are 
indicated on the x-axis of their respective figures. Dexamethasone 
suppresses adrenal and pituitary secretions allowing for the 
isolated adrenal response to an exogenous ACTH to be meas-
ured. DOC sensitivity, assessed by AUC, varied across the 
experimental phases [F(2,18) = 63.28, p < 0.0001; Figure 2A]. 
In line with our hypothesis of decreased adrenal sensitivity 
during ethanol induction, DOC AUC was significantly blunted 
during this phase compared to baseline (p = 0.0006). Following 
self-administration, DOC AUC was significantly greater than 
both baseline and induction (p < 0.0001), supporting heightened 
adrenal sensitivity to ACTH. Post-dexamethasone ACTH was 
generally found to be a weak stimulus for DOC secretion in these 
animals, as shown in the individual timecourses (Figures 2B–D). 
At baseline, there was no main effect of time [F(2,18) =  1.3, 
p = 0.30; Figure 2B], indicating DOC concentrations remained 
flat following the challenge. During induction, a moderate 
increase was seen [F(2,18) = 3.7, p = 0.05; Figure 2C], where 
DOC concentration 30 min after the challenge (0.35 ± 0.12 ng/
ml) was significantly higher compared to pre-challenge 
(t = −30; 0.24 ±  0.08  ng/ml). Following 6  months of ethanol 
self-administration, DOC showed an increased sensitivity to 
ACTH challenge [F(2,18) = 61.8, p < 0.0001; Figure 2D]. DOC 
concentrations peaked at t =  15  min (0.76 ±  0.13  ng/ml) and 
were significantly greater than baseline (p  <  0.0001). These 
results should be considered within the context of basal DOC 
levels (shown in Figure 1). Although the increase over the time-
course was found to be significant during both induction and 
self-administration, this is largely due to the low pre-challenge 
concentration as the peak concentration is not above basal levels 
at either experimental phase. The response to this challenge is 
in agreement with the results of basal DOC and supports our 
hypothesis of dampened adrenal sensitivity during ethanol 
induction and enhanced sensitivity during self-administration.
exogenous ocrh administration
Intravenous oCRH does not cross the blood–brain barrier, 
thus stimulating pituitary synthesis and secretion of ACTH 
without stimulating contribution from the hypothalamus. As 
shown in Figure  3A, the AUC response to oCRH varied by 
experimental phase [F(2,18) =  119.66, p <  0.0001]. Similar to 
post-dexamethasone ACTH, DOC AUC during induction was 
significantly reduced compared to baseline and self-administra-
tion (p <  0.001), and the AUC was significantly higher during 
self-administration when compared to baseline (p = 0.002). Prior 
to ethanol, peak DOC concentration in response to the oCRH 
challenge was 0.92 ± 0.40 ng/ml at t = 45 min (Figure 3B). Peak 
DOC was significantly dampened during ethanol induction 
(0.44 ±  0.22 ng/ml, t =  15 min; Figure 3C), and a heightened 
response was found during self-administration (1.36 ± 0.54 ng/
ml, t = 30 min; Figure 3D). These results provide further evidence 
of dampened adrenocortical DOC response to ACTH stimula-
tion during induction and a compensatory over-sensitization 
following self-administration.
FigUre 3 | Deoxycorticosterone (DOc) response to exogenous ovine crh (1.0 µg/kg) administration. The DOC response is summarized across the 
experimental phases by area under the curve (a). DOC concentrations for each timepoint sampled during baseline (B), induction (c), and self-administration (D) are 
shown. Symbols represent significant differences when compared to baseline (t = −15min). Animals are uniquely colored. ap < 0.05, *p < 0.01, **p < 0.001.
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naloxone challenge
Naloxone is a competitive opioid antagonist that releases the 
inhibitory tone on the HPA axis, stimulating synthesis and release 
of ACTH and adrenal steroids. As summarized in Figure 4A, DOC 
AUC varied across the experimental phases [F(2,18) =  55.61, 
p <  0.0001]. Compared to baseline, ethanol induction greatly 
potentiated the effect of naloxone (p  <  0.0001), which was 
reduced during self-administration (p <  0.0001, compared to 
induction), although in this latest phase it remained significantly 
elevated compared to baseline (p = 0.0006). Across the sampling 
timecourse, naloxone resulted in a moderate increase in DOC 
at baseline [F(4,36) =  4.13, p =  0.007, Figure  4B]. Peak DOC 
concentration measured at t = 90 min (0.83 ± 0.23 ng/ml) was sig-
nificantly higher compared to t = 15 (0.68 ± 0.20 ng/ml; p = 0.01) 
and t = 30 (0.67 ± 0.14 ng/ml; p = 0.008). During induction, there 
was a wide range in circulating DOC concentration across all 
timepoints that obscured any main effects of time [F(4,36) = 1.46, 
p =  0.23, Figure  4C, notice the scale of the y-axis]. Following 
6  months of ethanol self-administration, a significant effect of 
time was found [F(4,36) = 7.62, p < 0.0001, Figure 4D], and the 
peak concentration was measured at t = 120 min (1.3 ± 0.4 ng/
ml). These results suggest central mechanisms mediating HPA 
axis activity are under greater inhibitory control during ethanol 
induction. Such an increase in inhibitory opioid tone at the level 
of the hypothalamus may compensate for the decreased sensitiv-
ity of ACTH to glucocorticoid negative feedback.
The responses to the pharmacological challenges described so 
far were not found to be predictive or dependent on average daily 
ethanol intake, thus the specific effects of ethanol are unclear. To 
address this, animals were challenged with two doses of intragas-
tric ethanol (1.0 and 1.5 g/kg).
ethanol challenge
For both challenge doses, there was a main effect of time 
[1.0  g/kg: F(2,18)  =  51.85, p  <  0.0001, Figure  5A; 1.5  g/kg: 
F(2,18) = 44.09, p < 0.0001, Figure 5E]. DOC AUC was signifi-
cantly higher during induction compared to baseline (1.0 g/kg: 
p < 0.00001; 1.5 g/kg: p < 0.001) and self-administration (1.0 g/
kg: p < 0.001; 1.5 g/kg: p = 0.04). Although the AUC was lower 
during self-administration when compared to induction, it was 
still significantly elevated when compared to baseline (1.0 g/kg: 
p <  0.00001; 1.5  g/kg: p <  0.001). While these two challenge 
doses resulted in similar AUC across the experimental phases, 
average BEC differed between the challenges but were consistent 
across the experimental phases (1.0 g/kg: baseline: 92 ± 13 mg/
dl, induction: 92 ± 20 mg/dl, self-administration: 101 ± 20 mg/
dl; 1.5 g/kg: baseline: 149 ± 17 mg/dl, induction: 162 ± 19 mg/
dl, self-administration: 168 ± 26 mg/dl). These data indicate that 
metabolic tolerance is an unlikely source of any of the changes 
reported in these animals.
The individual timecourses show that both challenge doses 
of ethanol blunted circulating DOC. This effect was less robust 
during induction, as indicated by the rise in AUC, where percent 
reduction went from 50 to 22% following 1.0 g/kg (Figure 5C) 
and 41 to 12% following 1.5  g/kg (Figure  5G). During both 
baseline and induction the lowest DOC concentration was 
measured at 120 min following the challenge. Following ethanol 
self-administration, DOC suppression normalized, 31% for 1.0 g/
kg (Figure 5D) and 43% for 1.5 g/kg (Figure 5H). Thus, while 
direct activation of the HPA axis by the other pharmacological 
challenges resulted in an increase in circulating DOC, ethanol 
challenges produced the opposite effect. Similar to the naloxone 
challenge, AUC was elevated during induction, an effect primar-
ily due to the elevated baseline DOC concentrations.
DiscUssiOn
The current dataset is an extensive investigation of the mechanisms 
related to HPA axis activation that regulate DOC concentration 
over the course of ethanol induction and self-administration in 
non-human primates. In these animals, trained to participate 
in awake blood collection, the traditional circulating stress hor-
mones (ACTH and cortisol) are low and have a diurnal rhythm 
indicating low basal stress (30, 31). Thus, our blood collection 
procedure provides a stable condition under which the native 
circuitry regulating the adrenal output appears to be in homeo-
stasis at baseline and can serve as a comparative basis across the 
experimental phases. Furthermore, the state of the HPA axis 
within a phase of ethanol self-administration appears reliable 
as evidenced by elevated ACTH concentrations during ethanol 
induction, a finding we have previously reported in different 
samples from the same animals (32).
FigUre 5 | Deoxycorticosterone (DOc) response to 1.0 and 1.5 g/kg oral ethanol gavage. DOC response is summarized across the experimental phases 
by area under the curve [(a,e) respectively]. DOC concentrations for each timepoint sampled during baseline (B,F), induction (c,g), and self-administration (D,h) 
are shown. Symbols represent significant differences when compared to baseline (t = −30 min). Animals are uniquely colored. ap < 0.05, *p < 0.01, **p < 0.001, 
***p < 0.0001.
FigUre 4 | Deoxycorticosterone (DOc) response to naloxone (375 µg/kg) administration. The DOC response is summarized across the experimental 
phases by area under the curve (a). DOC concentrations for each timepoint sampled during baseline (B), induction (c), and self-administration (D) are shown. 
Symbols represent significant differences when compared to t = 15 (b) or t = 30 (c); see main text for specific p-values. Animals are uniquely colored. **p < 0.001, 
***p < 0.0001.
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Circulating DOC in human and non-human primates is 
mainly of adrenal origin, and its secretion is regulated by the 
HPA axis, in a manner similar to cortisol (26, 33–36). The data 
presented here further support a regulation of circulating DOC 
levels by the HPA axis under baseline conditions and following 
long-term ethanol exposure in cynomolgus monkeys. Overall, 
it appears that HPA axis regulation and feedback are disrupted 
by ethanol consumption under SIP parameters. This outcome 
is consistent with data showing schedules of reinforcement that 
generate SIP rely on establishing a conflict between aversive and 
appetitive aspects of the schedule (37). Once the induction sched-
ule is removed and the monkey is given 22 h/day (open access) to 
choose to drink ethanol or water, there is an immediate decrease 
in cortisol (32) and, by inference, a likely decrease in DOC. After 
6  months of daily open access ethanol self-administration, the 
DOC responses to the HPA axis challenges are lower than dur-
ing ethanol induction, although uniformly higher than baseline, 
suggesting that chronic ethanol self-administration results in a 
new allostatic state.
The large influence of the SIP condition is evidenced by 
the adaptation to pharmacological challenge between baseline 
and induction. These divergent, phase-dependent responses 
indicate a shift in HPA axis regulation of DOC that may 
be attributed to ethanol, the scheduled induction, or their 
combination. These data demonstrate that the adrenal cortex, 
specifically the zona fasciculata, is less sensitive to ACTH 
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stimulation (Figures  2 and 3) but more sensitive to hypo-
thalamic disinhibition (naloxone challenge, Figure  4). The 
heightened DOC response to naloxone during induction could 
indicate greater opioid receptor occupancy, as cortisol response 
to naloxone predicted μ-opioid receptor binding potential in 
positron-emission tomography studies of the hypothalamus, 
caudate, putamen, and ventral striatum of humans (38). From 
a homeostatic point of view, the heightened opioid control at 
the level of the hypothalamus could be a compensatory change 
established to rebalance control over HPA axis activity in 
response to dampened adrenal sensitivity to ACTH, resulting 
in an allostatic state (39). However, further studies are needed 
to address this hypothesis.
The development of an allostatic state following the ethanol 
self-administration protocol is clearly supported by the changes 
in basal (unchallenged, Figure  1A) DOC response across the 
experimental phases. Despite aberrant responses to naloxone and 
exogenous ACTH during induction, no differences were found in 
basal DOC between baseline and induction. However, following 
6 months of daily open access ethanol self-administration, when 
the responses to pharmacological challenges had moved toward 
their baseline levels of responding, basal circulating DOC became 
significantly higher than during either the preceding baseline or 
induction phases. Furthermore, although DOC remained reliably 
suppressed by the administration of 1.5 g/kg ethanol following 
prolonged self-administration, the suppression was delayed com-
pared to the initial (baseline) ethanol response. Thus, it appears 
that chronic ethanol consumption may increase circulating DOC 
and thereby the production of its neuroactive metabolites. In 
humans, any increase in basal DOC may be reversible as it has 
been reported that 1-month-abstinent alcoholics and controls 
had similar DOC, ACTH, progesterone, 17-OH-progesterone, 
aldosterone, androstenedione, DHEA, and pregnenolone sulfate 
levels (10, 36).
Importantly, the data presented here help characterize the cir-
cumstances of HPA axis activation of DOC secretion. Specifically, 
a dysregulation between HPA axis activation and DOC secretion 
at each level of the HPA axis was revealed, particularly during 
induction but also during chronic ethanol self-administration. In 
addition to the difference in 1-month-abstinent alcoholics cited 
above, these data are in contrast to a study that found ethanol 
administration for 3  weeks did not change basal DOC levels 
in the plasma or brain of rats (40). However, rats that received 
chronic (3  week) ethanol administration had decreased levels 
of corticosterone (41) and blunted ethanol-induced elevations 
of cerebral cortical 3α,5α-THP and DOC levels (40, 42). The 
apparent discrepancies in regulation of DOC responses following 
long-term ethanol exposure might be the result of species differ-
ences or the different experimental procedures, i.e., assessment 
immediately following relatively short term (3  weeks) alcohol 
exposure in rats (40) or long term (over 9 months of ethanol) 
in cynomolgus monkeys (present results) versus 1-month 
abstinence with a highly variable history of alcohol in humans 
(36). The results presented here support the need for a greater 
mechanistic understanding of ethanol-induced changes in 
steroidogenic pathways within the adrenal cortex, as well as the 
PVN and the specific contribution of the opioid receptors to the 
changes reported here.
It is important to consider the potential contribution of 
hormonal rhythms in the current results. The pharmacological 
challenges and blood samples were collected at the same time 
of day across the experimental timeline, but the seasonal 
contributions were not controlled. Adrenal and pituitary hor-
mones are known to have annual rhythms that are maintained 
under laboratory conditions in rhesus males (43). In humans, 
peak cortisol was reportedly higher in the winter compared to 
summer (44). Therefore, DOC concentration may also follow 
a seasonal pattern and be higher in the winter. However, both 
the baseline and 6-month self-administration challenges were 
performed during the winter (January and February of consecu-
tive years, respectively), while greatest DOC response was found 
following induction of ethanol, when seasonal rhythms would 
have predicted a lower response. Thus, seasonal differences in 
adrenal sensitivity do not appear to have contributed to the DOC 
responses reported here.
Overall, the hormone-specific effects of ethanol in macaques 
suggest unique effects in different zones of the adrenal cortex that 
require further study. As a first step, the present data show dif-
ferential effects of pre-ethanol, ethanol induction, and voluntary 
ethanol self-administration on opioid, ACTH, and glucocorticoid 
regulation of circulating DOC levels. These results have implica-
tions for neurosteroid activity in the brain, and we have shown 
that chronic ethanol self-administration protocol reduces 3α,5α-
THP in the amygdala (45). Furthermore, because the greatest 
adaptations in DOC response were found with opioid regulation 
of the HPA axis, it appears that circulating DOC is a reflection 
of chronic ethanol-induced long-term allostasis involving central 
mechanisms. However, future studies will need to better define 
the mechanism(s) supporting an allostatic state such as altered 
synthesis, release or degradation of DOC as well as altered 
pharmacodynamics of the opioid, ACTH, and glucocorticoid 
receptors that help regulate HPA axis activity.
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